معرفی
Dr. Karin Gehring is a Researcher at Tilburg University's Department of Cognitive Neuropsychology within the Tilburg School of Social and Behavioral Sciences. With over 100 publications spanning nearly two decades of research, she specializes in cognitive functioning in patients with brain tumors, particularly examining how conditions like gliomas and meningiomas impact cognitive performance before and after treatment. Her work contributes to Sustainable Development Goals related to health and well-being, focusing on improving quality of life for neuro-oncology patients.
Dr. Gehring's research program investigates cognitive impairments across multiple dimensions of brain tumor care. She examines how tumor location affects specific cognitive domains, how surgical intervention and radiotherapy impact cognitive trajectories, and develops prediction models for post-treatment cognitive functioning. Her recent work demonstrates an evolution toward more sophisticated analytical approaches, integrating machine learning, network neuroscience, and voxel-based analysis to understand the complex relationships between brain structure, treatment parameters, and cognitive outcomes. This methodological progression reflects her commitment to translating research findings into clinically useful tools for neuro-oncology care.
Analysis of Dr. Gehring's recent publications (2024-2025) reveals a strong focus on predictive modeling of cognitive outcomes, structural connectivity analysis, and advanced imaging techniques. Her work consistently addresses clinically relevant questions about when and why cognitive impairments occur following brain tumor treatment, with the ultimate goal of improving patient care through evidence-based interventions and decision support.
- Award for excellence in quality of life research from the International Society for Neuro-oncology (2008)
- Ties Rudolphie stimuleringsprijs recognizing contributions to brain tumor research (2008)
- Fellowship for Treatment of Cognitive Deficits in Patients with Primary Brain Tumors (2010)
Dr. Gehring serves as an editorial board member for Neuro-Oncology Practice since 2013 and is actively involved as a Principal Investigator in the 'De Sterkste Schakel' research project. Beyond her academic roles, she contributes to practical applications of her research through board positions with stichting 't Hoofdgerecht (managing the ReMind app for brain tumor patients) and Stichting Sport Support Arnhem. Her work exemplifies a translational research approach, bridging fundamental neuroscience with clinical applications to improve cognitive outcomes and quality of life for patients undergoing treatment for brain tumors.
